Cme Group Inc. financial data

Symbol
CME on Nasdaq
Location
20 S. Wacker Dr., Chicago, IL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % -0.36%
Debt-to-equity 460 % +25.8%
Operating Margin 65.3 % +3.91%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 70.4B USD +6.18%
Weighted Average Number of Shares Outstanding, Basic 360M shares +0.09%
Weighted Average Number of Shares Outstanding, Diluted 360M shares +0.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.44B USD +11.2%
Costs and Expenses 2.24B USD +3.78%
Operating Income (Loss) 4.21B USD +15.5%
Nonoperating Income (Expense) 640M USD +5.86%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.85B USD +14.1%
Income Tax Expense (Benefit) 1.08B USD +14.3%
Earnings Per Share, Basic 10 USD/shares +14%
Earnings Per Share, Diluted 10 USD/shares +14%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.98B USD +10.7%
Marketable Securities, Current 118M USD -3.37%
Accounts Receivable, after Allowance for Credit Loss, Current 668M USD +11.4%
Other Assets, Current 526M USD -7.38%
Assets, Current 145B USD +63.9%
Property, Plant and Equipment, Net 363M USD -5.62%
Operating Lease, Right-of-Use Asset 218M USD -12.8%
Goodwill 10.5B USD +0.34%
Other Assets, Noncurrent 3.67B USD +0.45%
Assets 180B USD +45.8%
Accounts Payable, Current 92.3M USD -7.61%
Liabilities, Current 143B USD +64.2%
Deferred Income Tax Liabilities, Net 5.23B USD -1.44%
Operating Lease, Liability, Noncurrent 253M USD -19%
Other Liabilities, Noncurrent 720M USD -8.04%
Liabilities 152B USD +58.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 45.4M USD
Retained Earnings (Accumulated Deficit) 5.25B USD -1.87%
Stockholders' Equity Attributable to Parent 27.7B USD +0.37%
Liabilities and Equity 180B USD +45.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.12B USD +25.1%
Net Cash Provided by (Used in) Financing Activities 19.2B USD +892%
Net Cash Provided by (Used in) Investing Activities -16M USD +29.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 20.3B USD +624%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 144B USD +64.8%
Deferred Tax Assets, Valuation Allowance 0 USD -100%
Deferred Tax Assets, Gross 142M USD +5.34%
Operating Lease, Liability 298M USD -17.2%
Depreciation 27.3M USD -4.88%
Payments to Acquire Property, Plant, and Equipment 14.2M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid 343M USD -19.8%
Property, Plant and Equipment, Gross 1.41B USD +5.06%
Operating Lease, Liability, Current 44.6M USD -4.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.9M USD -10.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 54.4M USD -6.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -7.4M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41.1M USD -18%
Deferred Tax Assets, Operating Loss Carryforwards 5.3M USD +55.9%
Preferred Stock, Shares Issued 4.6M shares 0%
Unrecognized Tax Benefits 252M USD -4.73%
Lessee, Operating Lease, Liability, to be Paid, Year Four 31.4M USD -36%
Operating Lease, Payments 73.5M USD +16.7%
Amortization of Intangible Assets 222M USD -0.54%
Deferred Tax Assets, Net of Valuation Allowance 142M USD +5.66%